| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3617 |
| Trial ID | NCT06080191 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19-CAR_Lenti_ALLO |
| Generation | 2th |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I Clinical Trial on the Use of Fresh, Allogeneic, Second-generation CD19-CAR T Cells for Treatment of Children With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia |
| Year | 2024 |
| Country | Italy |
| Company sponsor | Bambino Gesù Hospital and Research Institute |
| Other ID(s) | AlloCAR |
| Cohort 1 | |||||||||||
|
|||||||||||